Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93% Copper (click to learn more) Almonty Announces Intention to Relocate to the United States (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AVITA Medical Inc RCEL

Healthcare Biotechnology
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile... see more

Recent & Breaking News (NDAQ:RCEL)

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

GlobeNewswire 13 days ago

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

GlobeNewswire December 23, 2024

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

GlobeNewswire December 19, 2024

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 18, 2024

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

GlobeNewswire November 25, 2024

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

GlobeNewswire November 12, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire November 8, 2024

AVITA Medical Reports Third Quarter Financial Results

GlobeNewswire November 7, 2024

AVITA Medical to Announce Third Quarter 2024 Financial Results

GlobeNewswire October 10, 2024

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

GlobeNewswire September 12, 2024

AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference

GlobeNewswire September 10, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire August 8, 2024

AVITA Medical Reports Second Quarter Financial Results

GlobeNewswire August 8, 2024

AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales

GlobeNewswire August 1, 2024

AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care

GlobeNewswire July 31, 2024

AVITA Medical to Announce Second Quarter 2024 Financial Results

GlobeNewswire July 11, 2024

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

GlobeNewswire July 1, 2024

AVITA Medical Achieves Milestone with First Case Using RECELL GO

GlobeNewswire June 5, 2024

AVITA Medical Announces FDA Approval of RECELL GO

GlobeNewswire May 30, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire May 16, 2024